Spiro George Rombotis insider trades: Cyclacel Pharmaceuticals (CYCC) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Spiro reports to the SEC
Open-market buys and sales
25 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 21, 2023 | CYCC | ↑ Buy | 6,070 | $3.31 | $20K | Direct | Dec 26, 2023 (5d) |
| Nov 18, 2021 | CYCC | ↑ Buy | 4,000 | $4.50 | $18K | Direct | Nov 22, 2021 (4d) |
| May 21, 2013 | CYCC | ↑ Buy | 100,000 | $3.00 | $300K | Direct | May 24, 2013 (3d) |
| May 21, 2013 | CYCC | ↑ Buy | 100,000 | $3.00 | $300K | Direct | May 22, 2013 (1d) |
| Dec 23, 2011 | CYCC | ↑ Buy | 15,902 | $0.49 | $8K | Direct | Dec 27, 2011 (4d) |
| Sep 23, 2011 | CYCC | ↑ Buy | 29,100 | $0.52 | $15K | Direct | Sep 26, 2011 (3d) |
| Sep 23, 2011 | CYCC | ↑ Buy | 1,200 | $3.06 | $4K | Direct | Sep 26, 2011 (3d) |
| Sep 13, 2011 | CYCC | ↑ Buy | 12,000 | $0.67 | $8K | Direct | Sep 14, 2011 (1d) |
| Sep 13, 2011 | CYCC | ↑ Buy | 400 | $3.23 | $1K | Direct | Sep 14, 2011 (1d) |
| Aug 22, 2011 | CYCC | ↑ Buy | 9,232 | $0.73 | $7K | Direct | Aug 24, 2011 (2d) |
| Apr 23, 2010 | CYCC | ↓ Sell | 8,350 | $2.50 | $21K | Direct | Apr 27, 2010 (4d) |
| Dec 2, 2008 | CYCC | ↑ Buy | 3,000 | $0.37 | $1K | Direct | Dec 4, 2008 (2d) |
| Nov 20, 2008 | CYCC | ↑ Buy | 8,900 | $0.35 | $3K | Direct | Nov 21, 2008 (1d) |
| Nov 18, 2008 | CYCC | ↑ Buy | 19,000 | $0.47 | $9K | Direct | Nov 19, 2008 (1d) |
| Aug 19, 2008 | CYCC | ↑ Buy | 9,000 | $1.71 | $15K | Direct | Aug 19, 2008 (0d) |
| Jun 5, 2008 | CYCC | ↑ Buy | 10,000 | $2.03 | $20K | Direct | Jun 5, 2008 (0d) |
| May 21, 2008 | CYCC | ↑ Buy | 12,500 | $2.32 | $29K | Direct | May 21, 2008 (0d) |
| May 15, 2008 | CYCC | ↑ Buy | 15,000 | $2.59 | $39K | Direct | May 16, 2008 (1d) |
| Mar 20, 2008 | CYCC | ↑ Buy | 5,800 | $2.75 | $16K | Direct | Mar 21, 2008 (1d) |
| Dec 20, 2007 | CYCC | ↑ Buy | 2,400 | $5.48 | $13K | Direct | Dec 21, 2007 (1d) |
| Sep 15, 2006 | CYCC | ↑ Buy | 1,400 | $5.60 | $8K | Direct | Sep 18, 2006 (3d) |
| Sep 12, 2006 | CYCC | ↑ Buy | 100 | $5.95 | $595 | Direct | Sep 13, 2006 (1d) |
| Sep 11, 2006 | CYCC | ↑ Buy | 400 | $5.72 | $2K | Direct | Sep 12, 2006 (1d) |
| Sep 7, 2006 | CYCC | ↑ Buy | 600 | $4.67 | $3K | Direct | Sep 8, 2006 (1d) |
| Apr 17, 2006 | CYCC | ↑ Buy | 100 | $7.74 | $774 | Direct | May 18, 2006 (31d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Spiro George Rombotis's insider trades
Spiro George Rombotis is President and CEO at Cyclacel Pharmaceuticals (CYCC). Since Apr 17, 2006, Spiro has reported 24 open-market purchases worth $841K and 1 sale worth $21K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (16 filings), other transactions (2 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CYCC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.